Expression of β3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes

Journal of Lipid Research

Volumn 37, Issue 1, 1996, Pages 87-97

  Tavernier, Geneviève ^a   Barbe, Pierre ^a   Galitzky, Jean ^a   Berlan, Michel ^a   Caput, Daniel ^b   Lafontan, Max ^a   Langin, Dominique ^a,c  

^a CHU RANGUEIL   (France)

^b SANOFI   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

3 agonists; 3 adrenoceptors; catecholamines; lipolysis; white adipocytes

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPRANOLOL; ISOPRENALINE; NADOLOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MESSENGER RNA;

ADIPOCYTE; ADULT; ANIMAL EXPERIMENT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; DRUG EFFICACY; DRUG RECEPTOR BINDING; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; LIPOLYSIS; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SUBCUTANEOUS FAT; TISSUE DISTRIBUTION; ADIPOSE TISSUE; ADOLESCENT; ANIMAL; BIOSYNTHESIS; BREAST; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENETICS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; WISTAR RAT;

ADIPOCYTES; ADIPOSE TISSUE; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANIMALS; BASE SEQUENCE; BREAST; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIPOLYSIS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; RNA, MESSENGER;

EID: 0029670720     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Lafontan, M., and M. Berlan. 1993. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid Res. 34: 1057-1091.
2. Lands, A. M., A. M. Arnold, J. P. McAuliff, and F. P. Luduena. 1967. Differentiation of receptor systems activated by sympathomimetic amines. Nature. 214: 597-598.
3. Arch, J. R. S., A. T. Ainsworth, M. A. Cawthorne, V. Piercy, M. V. Sennitt, V. E. Thody, C. Wilson, and S. Wilson. 1984. Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature. 309: 163-165.
4. Hollenga, C., and J. Zaagsma. 1989. Direct evidence for the atypical nature of functional β-adrenoceptors in rat adipocytes. Br. J. Pharmacol. 98: 1420-1424.
5. Langin, D., M. Portillo, J-S. Saulnier-Blache, and M. Lafontan. 1991. Coexistence of three β-adrenergic receptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol. 199: 291-301.
6. 3-adrenergic receptor. Science. 245: 1118-1121.
7. Muzzin, P., J-P. Revelli, F. Kuhne, J. D. Gocayne, W. R. McCombie, J. C. Venter, J-P. Giacobino, and C. Fraser. 1991. An adipose tissue specific β-adrenergic receptor. Molecular cloning and down-regulation in obesity. J. Biol. Chem. 266: 24053-24058.
8. 3-adrenergic receptor. Mol. Pharmacol. 40: 895-899.
9. 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J. 10: 3721-3727.
10. 3-adrenergic receptor cDNA. FEBS Lett. 324: 127-130.
11. 3-adrenoceptor"? Trends Pharmacol. Sci. 11: 3-7.
12. 3-Adrenergic agonists. Drugs Future. 18: 529-549.
13. 3-adrenergic response: comparison with human adipocytes. Am. J. Physiol. 266: R905-R913.
14. Bousquet-Mélou, A., J. Galitzky, C. Carpéné, M. Lafontan, and M. Berlan. 1994. β-Adrenergic control of lipolysis in primate white fat cells: a comparative study with nonprimate mammals. Am. J. Physiol. 267: R115-R123.
15. Hollenga, C., M. Haas, J. T. Deinum, and J. Zaagsina. 1990. Discrepancies in lipolytic activities induced by β-adrenoceptor agonists in human and rat adipocytes. Horm. Metab. Res. 22: 17-21.
16. 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J. Clin. Endocrinol. & Metab. 77: 352-355.
17. Van Liefde, I., A. Van Ermen, and G. Vauquelin. 1994. No functional atypical β-adrenergic receptors in human omental adipocytes. Life Sci. 54: PL209-214.
18. 3-adrenoceptor in man. Br. J. Pharmacol. 110: 929-936.
19. 3-adrenoceptors in obesity. J. Clin. Invest. 95: 1109-1116.
20. 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol. Pharmacol. 43; 343-348.
21. 3-adrenergic receptor genes contain an intron within the protein-coding block. Mol. Pharmacol. 42: 964-970.
22. 3-adrenergic receptor mRNA in man. J. Clin. Invest. 91: 344-349.
23. Rodbell, M. 1964. Metabolism of isolated fat cells. I Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 29: 375-380.
24. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
25. Bradley, D. C., and H. R. Kaslow. 1989. Radiometric assays for glycerol, glucose, and glycogen. Anal. Biochem. 180: 11-16.
26. Stahle, L., P. Arner, and U. Ungerstedt. 1991. Drug distribution studies with microdialysis. III extracellular concentration of caffeine in adipose tissue in man. Life Sci. 49: 1853-1858.
27. Hickner, R. C., H. Rosdahl, I. Borg, U. Ungerstedt, L. Jorfeldt, and J. Henriksson. 1991. Ethanol may be used with the microdialysis technique to monitor blood flow changes in skeletal muscle: dialysate glucose concentration is blood flow-dependent. Acta Physiol. Scand. 143: 355-356.
28. 2-adrenoceptors in regulating lipid mobilization from human adipose tissue. J. Clin. Invest. 91: 1997-2003.
29. Cassard, A. M., F. Bouillaud, M. G. Mattei, E. Hentz, S. Raimbault, M. Thomas, and D. Ricquier. 1990. Human uncoupling protein gene structure, comparison with rat gene and assignment to the long arm of chromosome 4. J. Cell. Biochem. 43: 255-264.
30. Legoux, P., C. Minty, B. Delpech, AJ. Minty, and D. Shire. 1992. Simultaneous quantitation of cytokine mRNAs in interleukin-1β-stimulated U373 human astrocytoma cells by a polymerisation chain reaction method involving co-amplification with an internal multi-specific control. Eur. Cytokine Netw. 3: 553-563.
31. 1- and atypical β-adrenergic receptors cause redundant increase in cyclic AMP in human neuroblastoma cells. Mol. Pharmacol. 42: 753-759.
32. 3-Adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines. J. Pharmacol. Exp. Ther. 266: 358-366.
33. 3H]CGP12177. J. Lipid Res. 27: 368-376.
34. 3- and atypical β-adrenoceptors. Med. Res. Rev. 13: 663-729.
35. 3-adrenergic receptors. J. Clin. Invest. 95: 923.
36. Arner, P., L. Hellström, H. Wahrenberg, and M. Brönnegard. 1990. β-Adrenoceptor expression in human fat cells from different regions. J. Clin. Invest. 86: 1595-1600.
37. 3-adrenoceptor messenger ribonucleic acids in adipose tissues. Endocrinology. 130: 109-114.
38. 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol. Endocrinol. 8: 518-527.
39. 3-agonist, on energy balance in brown and white adipose tissue in rats. Am. J. Physiol. 266: R1371-R1382.
40. Nisoli, E., C. Tonello, and M. O. Carruba. 1994. SR 58611A: a novel thermogenic β-adrenoceptor agonist. Eur. J. Pharmacol. 259: 181-186.
41. 3-Adrenoccptor selectivity of the dioxolane dicarboxylate phenethanolamines. J. Pharmacol. Exp. Ther. 269: 1000-1006.
42. Wheeldon, N. M., D. G. McDevitt, L. C. McFarlane, and B. J. Lipworth. 1994. β-Adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man. Clin. Sci. 86: 331-337.
43. 3-adrenoceptor. Br. J. Pharmacol. 112: 911-919.
44. 3-adrenoceptor in man. J. Clin. Invest. 95: 2239-2245.
45. Kenakin, T. 1993. Competitive antagonism. In Pharmacologic Analysis of Drug-Receptor Interaction. T. Kenakin, editor. Raven Press, New York. 278-322.
46. 3-adrenoceptors mediate metabolic responses to isoprenaline? Q. J. Med. 86: 595-600.
47. Van Baak, M. A., E. Thijssen, E. E. Blaak, and W. H. Saris. 1995. β-Adrenoceptor subtypes mediating the stimulation of energy expenditure and lipolysis by isoprenaline. Int. J. Obesity. 19: S2. 41 (Abs.).
48. 3-adrenergic receptor stimulation in conscious dogs. J. Pharmacol. Exp. Ther. 268: 466-473.